Home›Stock Screener›JFL Life Sciences

JFL Life Sciences Share Price Today | Stock Price & JFL Life Sciences Share Screener

JFLLIFE Pharmaceuticals & Biotechnology

Track the current JFL Life Sciences share price and stock price live with TickJournal's free stock screener. Track JFL Life Sciences market cap to gauge the company's total market size. Use the JFL Life Sciences stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today JFL Life Sciences opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹200 and net income of ₹9, with EBITDA of ₹16, an operating margin of 11.0% and a profit margin of 4.5%.

JFL Life Sciences Market Cap ₹81.50 Cr.
JFLLIFE P/E Ratio (TTM) 4.70
JFL Life Sciences P/B Ratio 0.83
EPS (TTM) ₹1.94
Dividend Yield 1.93%
Debt to Equity 0.38
JFLLIFE 52 Week High -
JFL Life Sciences 52 Week Low -
Operating Margin 11.00%
Profit Margin 4.50%
JFLLIFE Revenue (TTM) ₹200.00
EBITDA ₹16.00
Net Income ₹9.00
Total Assets ₹106.00
Total Equity ₹46.00

JFL Life Sciences Share Price Chart

Track the current stock price of JFL Life Sciences with an interactive chart. Analyse JFLLIFE share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete JFL Life Sciences stock quote in one place.

JFL Life Sciences Company Profile - Fundamental Screener

Screen JFL Life Sciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JFLLIFE shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE0LA901015.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE0LA901015

JFL Life Sciences Balance Sheet Screener

Screen JFLLIFE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹106, up from ₹72 in 2025.

Latest statistics put total assets at ₹106 and shareholder funds at ₹46, with a leverage ratio of 0.38.

Item 2026 2025 2024 2023 2022 2021 2020 2019

Assets

Total Assets 106 72 57 49 48 29 24 16
Current Assets 0 0 0 0 0 0 0 0
Fixed Assets 15 12 13 7 7 7 5 3

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0
Current Liabilities 7 1 1 2 9 8 1 3
Non-Current Liabilities 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 46 40 36 32 11 7 5 5
Share Capital 33 33 11 11 8 1 0 0
Reserves & Surplus 13 7 25 21 3 6 5 5

JFL Life Sciences Income Statement Screener - Profit & Revenue Analysis

Screen JFL Life Sciences income statement and profit fundamentals. Analyze JFLLIFE quarterly results. JFL Life Sciences reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹200 and net profit was ₹9, equal to earnings per unit of ₹2.70, at an operating margin of 11%.

In that period expenses were ₹184, interest cost ₹2 and tax ₹3. The next period listed, 2026-March, shows revenue of ₹132 and net profit of ₹6.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Revenue and Expenses

Revenue 200 132 82 47 45 35 33 30 32
Expenses 184 120 74 42 39 28 31 28 31

Operating Costs and Margins

EBITDA 16 12 8 5 6 6 2 2 1
Operating Profit % 11.00% 9.00% 10.00% 10.00% 9.00% 16.00% 7.00% 6.00% 4.00%
Depreciation 1 1 1 0 0 0 0 0 0
Interest 2 2 1 1 1 2 1 1 1

Profit and Earnings

Profit Before Tax 12 9 6 4 4 4 1 1 0
Tax 3 2 2 1 1 1 0 0 0
Net Profit 9 6 4 3 3 3 1 0 0
EPS 2.70 1.94 1.26 1.00 2.90 4.12 0.89 0.66 0.59

JFL Life Sciences Cash Flow Screener - Liquidity Fundamentals

Screen JFLLIFE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities used ₹4, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹4 and financing activities provided ₹9.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March

Cash from Operations and Investing

Operating Activities -4 -4 8 -9 2 -6 3 -3
Investing Activities -4 0 -6 1 -1 -2 -3 -1

Financing and Net Cash

Financing Activities 9 4 -2 8 -2 7 0 4
Net Cash Flow 1 0 0 0 0 0 0 0

JFL Life Sciences Shareholding Pattern Screener

See JFL Life Sciences shareholding pattern with promoter, FII, and DII holdings. Check JFL Life Sciences promoter holding and ownership changes for JFLLIFE on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 67.47%, foreign institutions 0.00%, domestic institutions 0.00% and the public 28.49%, spread across 971 shareholders.

The shareholder count was 971 in 2026-Mar, compared with 943 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 67.47% 67.47% 67.47% 67.47% 67.47% 67.47% 67.47% 67.47%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 28.49% 28.31% 28.42% 28.77% 28.95% 28.88% 28.54% 28.06%
Other Holding 4.04% 4.22% 4.12% 3.76% 3.58% 3.66% 3.99% 4.47%
Shareholder Count 971 943 904 997 1,022 998 991 825

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by JFL Life Sciences. JFL Life Sciences dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.25 per unit.

Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹0.00 0.00%
2024-March ₹0.25 1.43%
2023-March ₹0.00 0.00%
2022-March ₹0.00 0.00%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.00 0.00%
2018-March ₹0.00 0.00%
2017-March ₹0.00 0.00%

JFL Life Sciences Stock Index Membership - Nifty & Sensex

See which indices include JFL Life Sciences stock. Check JFLLIFE index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

JFL Life Sciences is not part of any tracked indices.
Only major market indices are tracked in our system.

JFL Life Sciences Market Events Screener - Corporate Actions

Get JFL Life Sciences corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check JFL Life Sciences stock events that may affect JFLLIFE share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 2, 2026, with a record date of November 2, 2026.

It is followed by Quarterly Result Announcement dated August 10, 2026 and Quarterly Result Announcement dated May 29, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-02 2026-11-02 Quarterly Result Announcement NA -9.26%
2026-08-10 2026-08-10 Quarterly Result Announcement NA 3.02%
2026-05-29 2026-05-29 Quarterly Result Announcement NA -4.92%
2026-01-29 2026-01-29 Quarterly Result Announcement NA -2.43%
2025-11-11 2025-11-11 Quarterly Result Announcement NA -2.17%
2025-10-28 2025-10-28 Extraordinary General Meeting NA 1.16%
2025-08-11 2025-08-11 Quarterly Result Announcement NA 1.42%
2025-05-19 2025-05-19 Quarterly Result Announcement NA 20.85%
2025-04-08 2025-04-08 Quarterly Result Announcement NA 4.52%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 26.39%
2024-09-24 2024-09-24 Bonus 2:1 1.06%
2024-09-23 2024-09-23 Annual General Meeting NA 9.54%
2024-09-13 2024-09-16 Dividend ₹ 0.25 /share 4.68%

JFL Life Sciences Competitors Screener - Peer Stocks Comparison

Screen JFLLIFE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 448,580 40.80 61,674 12.69% 11,565 60.46
Divis Laboratories 297,219 87.70 11,067 13.95% 2,568 68.76
Torrent Pharmaceuticals 177,681 84.70 13,886 20.34% 2,138 47.23
Laurus Labs 126,336 94.90 6,868 22.01% 890 57.04
Zydus Life Science 119,800 27.90 27,658 17.64% 5,026 55.91
Dr Reddys Laboratories 115,269 42.00 35,059 3.90% 4,158 71.26
Cipla 112,308 39.20 29,045 2.24% 3,870 53.06
Mankind Pharma 108,416 47.50 14,636 14.85% 1,938 61.37
Aurobindo Pharma 103,183 25.90 34,145 5.56% 3,503 60.39
Lupin 89,464 17.10 29,039 26.75% 5,356 39.39

JFL Life Sciences Company Announcements - News & Reports Screener

Screen JFLLIFE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

No company announcements available.

Frequently Asked Questions

How is the company valued right now?

The P/E ratio is 4.70 and the P/B ratio is 0.83, with earnings per unit of ₹1.94. Market capitalisation stands at ₹81.50 Cr and the dividend yield is 1.93%. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Key statistics were last updated on November 18, 2026. This page covers 8 balance sheet periods, 9 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.